Introduction

Biologique Recherche, the French luxury skincare house renowned for its personalized, biotech-driven formulas, is navigating a significant leadership transition. After just over a year at the helm, former CEO Jean-Guillaume Trottier has stepped down, prompting the brand to install co-CEO leadership as it evaluates its next chapter.

What Happened

Industry sources confirm that Trottier, who guided the company since January 2024, has departed. Rupert Schmid and Pierre-Louis Delapalme, previously vice chairmen of the supervisory board, have stepped into co-CEO positions on an interim basis. The brand is also believed to have initiated a formal sales process, signaling potential ownership changes.

Why This Matters

The leadership shift comes as Biologique Recherche reports approximately 150 million euros in annual sales, a substantial increase from roughly 40 million euros a few years prior. With a global footprint spanning 74 countries and a newly opened New York City flagship, the brand's direction is closely watched by investors, retailers and wellness enthusiasts, especially as the clinical skincare market intensifies post-pandemic.

Key Takeaways

  • Trottier's departure marks the latest executive transition for the 40-year-old brand.
  • Rupert Schmid and Delapalme will guide operations while the sales process unfolds.
  • The brand has seen sales triple in recent years, reflecting strong market demand.
  • The U.S. retail footprint has expanded by 40 new doors through Bloomingdale's, Nordstrom, and others.
  • Founder Philippe Allouche remains at the helm of product creation and formulation.

Conclusion

As Biologique Recherche moves forward under interim co-CEO leadership, the industry will be watching whether this structure stabilizes the brand or precedes a full transition. Regardless, the company's commitment to biotech innovation and personalized professional care remains at the core of its identity, and its next phase could reshape its position in the global luxury skincare landscape.